LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 868 | 777 | 3486 | 0.2229 | -0.0348 |
MDA-MB-231 | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 868 | 2712 | 3486 | 0.7781 | 0.7045 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 868 | 3487 | 3486 | 1.0004 | 1.0005 |
MDA-MB-231 | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 868 | 2901 | 3486 | 0.8323 | 0.7767 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 868 | 3236 | 3486 | 0.9284 | 0.9046 |
MDA-MB-231 | R406 | 0.04 | uM | LJP6 | 72 | hr | 868 | 3428 | 3486 | 0.9834 | 0.9778 |
MDA-MB-231 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 868 | 2501 | 3486 | 0.7174 | 0.6237 |
MDA-MB-231 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 868 | 4066 | 3486 | 1.1664 | 1.2216 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 868 | 1313 | 3486 | 0.3766 | 0.1699 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 868 | 1639 | 3486 | 0.4703 | 0.2947 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 868 | 3825 | 3486 | 1.0972 | 1.1294 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 868 | 3909 | 3486 | 1.1212 | 1.1614 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 868 | 2588 | 3486 | 0.7424 | 0.6570 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 868 | 2095 | 3486 | 0.6011 | 0.4688 |
MDA-MB-231 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 868 | 2658 | 3486 | 0.7625 | 0.6837 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 868 | 2934 | 3486 | 0.8417 | 0.7892 |
MDA-MB-231 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 868 | 3097 | 3486 | 0.8884 | 0.8514 |
MDA-MB-231 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 868 | 2470 | 3486 | 0.7086 | 0.6119 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 868 | 3834 | 3486 | 1.0998 | 1.1329 |
MDA-MB-231 | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 868 | 2621 | 3486 | 0.7518 | 0.6695 |
MDA-MB-231 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 868 | 2560 | 3486 | 0.7344 | 0.6463 |
MDA-MB-231 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 868 | 3009 | 3486 | 0.8632 | 0.8178 |
MDA-MB-231 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 868 | 3684 | 3486 | 1.0567 | 1.0755 |
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 868 | 3905 | 3486 | 1.1201 | 1.1599 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 868 | 2600 | 3486 | 0.7460 | 0.6617 |